Real-World Data Collection of GORE Devices Used In the Endovascular Treatment of Aortic Aneurysms Which Incorporate Visceral Arteries.

Who can take part

• Informed Consent Form (ICF) is signed by Subject
• Age ≥ 18 years at time of informed consent signature
• Patient presents with thoracoabdominal, pararenal, juxtarenal, or short-neck infrarenal aortic pathology suitable for endovascular repair
• Patient requires the incorporation of ≥ 1 visceral artery and is suitable for use of at least 1 GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (BXB) as a bridging stent (Note: Up to six (6) visceral arteries may be incorporated)
• Patient is willing to adhere to the institutional standard of care follow-up

Who cannot take part

• Patient has a prior visceral artery stenting not associated with registry procedure
• Patient is intended to be treated with a parallel grafting (e.g., chimney, periscope, sandwich) or octopus technique
• Known hypersensitivity to heparin or a previous incident of Heparin-Induced Thrombocytopenia (HIT) type II
• Patient has known coagulation disorders including hypercoagulability that are not amenable to treatment
• Patient treated for acute or sub-acute dissection, <90 days from onset of symptoms
• Patient has a life expectancy < 1-year
• Patient is participating in an investigational study which may confound registry results, unless approved by Gore